. 2014 Oct 30;11(2):783–790. doi: 10.3892/mmr.2014.2826

Table II.

LTβR, p65 (RelA) and RelB mRNA expression in the healthy bladder mucosa, chronic cystitis and BCa groups.

Group (N)	LTβR/GAPDH mRNA ×10³ median (P₂₅-P₇₅)	p65/GAPDH mRNA ×10³ median (P₂₅-P₇₅)	RelB/GAPDH mRNA ×10³ median (P₂₅-P₇₅)
Healthy bladder mucosa (23)	1.2 (0.3–7.0)	1.0 (0.8–1.8)	0.2 (0.04–0.2)
Chronic cystitis (10)	6.8 (1.3–22.7)^a	2.8 (1.9–7.1)^a	0.4 (0.1–0.9)^a
BCa (81)	29.8 (16.8–50.9)^a,^b	10.2 (3.2–21.8)^a,^b	1.8 (0.5–3.6 )^a,^b

P<0.05 compared to the healthy bladder mucosa group;

P<0.05 compared to the healthy bladder mucosa and chronic cystitis group.

LTβR, lymphotoxin β receptor; BCa, bladder cancer; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; P₂₅–P₇₅, percentile 25–75%.